The Dialysis Access Center

Filter Your Results

 

News

 

Holy Name Medical Center Enrolls Its First Patient in Medtronic's IN.PACT AV Access DCB Study

July 19, 2017 -- Holy Name Medical Center in Teaneck, New Jersey, recently announced that it has enrolled the center's first patient in the IN.PACT Arteriovenous (AV) Acce…

Fresenius Vascular Care Changes Name to Azura

June 20, 2017 -- Fresenius Vascular Care announced its new name, Azura Vascular Care, as part of a strategic rebranding initiative. A phased rollout of the new brand across al…

Twelve-Month NEAT Results Published for TVA Medical's everlinQ endoAVF System

June 15, 2017 -- TVA Medical, Inc. announced that 12-month results from the Novel Endovascular Access Trial (NEAT) were published online by Charmaine E. Lok, MD, et al in Amer…

Paclitaxel Versus Plain Balloon Angioplasty Compared in Treatment of Symptomatic Central Venous Stenosis in Dialysis Access

June 14, 2017 -- Results from a randomized controlled trial comparing the clinically assessed intervention-free period (IFP) of paclitaxel-coated balloon (PCB) angioplasty ver…

Cagent Vascular's Serranator Alto Balloon Catheter Receives FDA Clearance

February 27, 2017 -- Cagent Vascular announced US Food and Drug Administration 510(k) clearance of the company's first product, the Serranator Alto percutaneous trans…

Indication Expanded for AV Medical’s Chameleon Balloon Catheter to Include Infusion of Diagnostic or Therapeutic Fluids

February 27, 2017 -- AV Medical Technologies, Ltd. announced that the company's Chameleon percutaneous transluminal angioplasty (PTA) balloon catheter has received clearan…

New Data on TVA Medical’s everlinQ endoAVF System for Endovascular Hemodialysis Access Presented at LINC 2017

January 26, 2017 -- TVA Medical, Inc. announced that data from several studies on the company’s everlinQ endoAVF System, an endovascular technique to create hemodialysis…

Medtronic to Begin IDE Study for In.Pact Admiral DCB AV Fistula Indication

January 26, 2017 -- Medtronic announced it has received an investigational device exemption from the US Food and Drug Administration (FDA) to commence a new study of its In.Pa…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.